動物模型市場 - 全球產業規模、佔有率、趨勢、機會和預測，按動物類型、應用、配銷通路、地區和競爭細分，2020-2030 年預測

2024 年全球動物模型市場價值為 18.9 億美元，預計到 2030 年將達到 30.2 億美元，預測期內複合年成長率為 8.12%。全球動物模型市場是生命科學產業中一個充滿活力且快速發展的領域，是生物醫學研究和藥物開發的重要工具。動物模型包括從小鼠、大鼠到靈長類動物等多種物種，用於模擬人類的生理和病理狀況，使科學家能夠研究疾病、測試潛在的治療方法並獲得對生物機制的寶貴見解。由於對製藥和生物技術研究的投資不斷增加、對個人化醫療的需求不斷成長以及對創新療法和疫苗的需求，全球動物模型市場有望大幅成長。

主要市場促進因素

慢性病盛行率上升

主要市場挑戰

倫理關注與動物福利的發展

主要市場趨勢

不囓齒動物模型的進展

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球動物模型市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依動物類型（小鼠、大鼠、豚鼠、兔子、倉鼠、其他）
  • 依應用分類（癌症、免疫疾病、傳染病、其他）
  • 依配銷通路（製藥及生技公司、學術研究機構、合約研究組織）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 依動物類型
  • 按應用
  • 按配銷通路
  • 按地區

第5章：亞太動物模型市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依動物類型
  • 按應用
  • 按配銷通路
  • 按國家
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第6章：歐洲動物模型市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第7章：北美動物模型市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲動物模型市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 9 章：中東與非洲動物模型市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 驅動程式
• 挑戰

第 11 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 12 章：全球動物模型市場：SWOT 分析

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Animal Model Market was valued at USD 1.89 billion in 2024 and and is expected to reach USD 3.02 billion by 2030 with a CAGR of 8.12% during the forecast period. The global animal model market is a dynamic and rapidly evolving sector of the life sciences industry, serving as a crucial tool for biomedical research and drug development. Animal models, which include a wide range of species from mice and rats to primates, are utilized to mimic human physiological and pathological conditions, enabling scientists to study diseases, test potential treatments, and gain valuable insights into biological mechanisms. The global animal model market is poised for substantial growth due to increasing investments in pharmaceutical and biotechnology research, rising demand for personalized medicine, and the need for innovative therapies and vaccines.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant factor propelling the growth of the global animal model market. Chronic diseases, including cancer, diabetes, cardiovascular conditions, and neurological disorders, have reached epidemic proportions worldwide, imposing a substantial burden on healthcare systems and economies. In response to this health crisis, there is an ever-increasing demand for effective treatments and therapies. Animal models are at the forefront of preclinical research, providing a vital tool for understanding disease mechanisms and testing potential interventions.

According to WHO, Noncommunicable diseases (NCDs) killed at least 43 million people in 2021, equivalent to 75% of non-pandemic-related deaths globally. In 2021, 18 million people died from an NCD before age 70 years; 82% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases account for most NCD deaths, or at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million including kidney disease deaths caused by diabetes).

Animal models serve as invaluable surrogates for human physiology, offering a means to simulate the complexities of chronic diseases and study their progression. Researchers can replicate the pathophysiological processes within animals, allowing for the investigation of disease etiology, drug efficacy, and safety profiles. This capability significantly reduces the inherent risks of advancing unproven therapies directly to human clinical trials.

Moreover, the use of animal models enables researchers to explore novel therapeutic avenues, develop innovative drug candidates, and fine-tune treatment regimens. By replicating the pathological conditions of chronic diseases in animal subjects, scientists can gain insights into potential therapeutic targets and mechanisms that would be challenging to investigate in any other way.

Key Market Challenges

Development of Ethical Concerns and Animal Welfare

The global animal model market, a linchpin of biomedical research and drug development, faces a formidable challenge from the escalating ethical concerns surrounding animal welfare. As society becomes increasingly conscious of the moral implications of using animals in research, these concerns have the potential to hinder the growth and evolution of the animal model market.

One of the central challenges is the ethical dilemma associated with animal experimentation. Many individuals, animal welfare organizations, and advocacy groups contend that the use of animals in research raises serious ethical questions regarding the treatment and suffering of sentient beings. The debate over the morality of using animals for scientific experiments has led to increasing calls for more stringent regulations and the development of alternative methods that do not involve animals.

As ethical concerns grow, there is greater scrutiny of animal welfare in research settings. Researchers are under increasing pressure to improve animal care, reduce suffering, and minimize the use of animals whenever possible. This, in turn, has raised the bar for standards and practices in the field, leading to more rigorous requirements for housing, enrichment, and veterinary care of research animals. These higher standards often translate into additional costs for research institutions and organizations.

Key Market Trends

Advancements in Non-Rodent Models

Advancements in non-rodent models are emerging as a significant driver behind the growth of the global animal model market. While rodents, particularly mice and rats, have traditionally been the primary subjects of animal research, there is a growing trend towards diversification as researchers seek more physiologically relevant models that closely mimic human biology. Non-human primates, pigs, dogs, and other species are becoming increasingly valuable in various research applications, driving the market's expansion and adaptability.

Non-rodent animal models offer several advantages. They provide a closer approximation of human physiology, making them crucial for translational research where the goal is to bridge the gap between preclinical studies and human clinical trials. For example, non-human primates share a closer genetic and physiological resemblance to humans, making them invaluable in the development of therapies for diseases with complex genetic and immunological components.

Key Market Players

• Charles River Laboratories
• The Jackson Laboratory
• genOway
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd

Report Scope:

In this report, the Global Animal Model Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Model Market, By Animal Type:

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Animal Model Market, By Application:

• Cancer
• Immunological Disease
• Infectious Disease
• Others

Animal Model Market, By Distribution Channel:

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

Animal Model Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Model Market.

Available Customizations:

Global Animal Model Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Animal Model Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Animal Type (Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Others)
  • 4.2.2. By Application (Cancer, Immunological Disease, Infectious Disease, Others)
  • 4.2.3. By Distribution Channel (Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Animal Type
  • 4.3.2. By Application
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. Asia Pacific Animal Model Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type
  • 5.2.2. By Application
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Animal Model Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Animal Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By Distribution Channel
  • 5.3.2. India Animal Model Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Animal Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By Distribution Channel
  • 5.3.3. Australia Animal Model Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Animal Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By Distribution Channel
  • 5.3.4. Japan Animal Model Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Animal Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By Distribution Channel
  • 5.3.5. South Korea Animal Model Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Animal Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By Distribution Channel

6. Europe Animal Model Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Application
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Animal Model Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Germany Animal Model Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Spain Animal Model Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Distribution Channel
  • 6.3.4. Italy Animal Model Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Animal Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Distribution Channel
  • 6.3.5. United Kingdom Animal Model Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Animal Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Distribution Channel

7. North America Animal Model Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Application
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Animal Model Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Mexico Animal Model Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Canada Animal Model Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Distribution Channel

8. South America Animal Model Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Application
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Animal Model Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Argentina Animal Model Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Colombia Animal Model Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Distribution Channel

9. Middle East and Africa Animal Model Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Application
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Animal Model Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Saudi Arabia Animal Model Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. UAE Animal Model Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Distribution Channel

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Animal Model Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Charles River Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. The Jackson Laboratory
• 14.3. genOway
• 14.4. Taconic Biosciences, Inc.
• 14.5. Janvier Labs
• 14.6. Harbour BioMed
• 14.7. Crown Bioscience
• 14.8. Inotiv
• 14.9. BIOCYTOGEN
• 14.10.BioSpherix, Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer